论文信息 - Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi - 字舞流文

Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi

N. Maine | Janet Darbyshire | A. Chihana | L. Bliss | I Cree | M. Pike | R. Peto | I. Cree | J. Darbyshire | S. Lucas | D. Nyangulu | J. Glynn | Richard Peto | S. Malema | M C Pike | A C McDougall | V. Mwinuka | J. M. Ponnighaus | E. Msosa | P. A. Jenkins | D. G. Clayton | P. Jenkins | Fine Pem. | D. K. Warndorff | Gruer Pjk. | S. M. Oxborrow | Pharoah Pdp. | Sebastian Lucas | D. Chavula | G. K Msiska | M. M. Munthali | B Mwamondwe | D Ngoma | P Nkhosa | H Phiri | M Simfukwa | D Kawaonja | S Malema | Venance Mwinuka | P Mkandawire | S. Nyasulu | H Tegha | M. Kalambo | S. Kileta | M Simwaka | J Saul | Sterne Jac. | J. R. Glynn | D Bell | David G. Clayton | K Desikan | Gupte | R R Jacobson | D S Nyangulu | D. Ngoma | D. Warndorff | L. Bliss | Fine Pem. | J. Ponnighaus | Gruer Pjk. | S. Oxborrow | Pharoah Pdp. | A. Mcdougall | D. Chavula | G. Msiska | E. Msosa | M. Munthali | B. Mwamondwe | P. Nkhosa | H. Phiri | M. Simfukwa | A. Chihana | D. Kawaonja | P. Mkandawire | S. Nyasulu | H. Tegha | M. Kalambo | S. Kileta | M. Simwaka | J. Saul | N. Maine | Sterne Jac. | D. Bell | K. Desikan | R. Jacobson

[1] J. Sterne,et al. Is HIV infection a risk factor for leprosy? , 1991, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[2] P. Fine,et al. Comparability among histopathologists in the diagnosis and classification of lesions suspected of leprosy in Malawi. , 1986, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[3] D. Rose,et al. The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS. , 1993, AIDS.

[4] M. Chakraborty,et al. Recurrent Japanese encephalitis epidemics in West Bengal. , 1980 .

[5] M. Pike,et al. The Karonga Prevention Trial: a leprosy and tuberculosis vaccine trial in northern Malaŵi. I. Methods of the vaccination phase. , 1993, Leprosy review.

[6] P. Fine. Reflections on the elimination of leprosy. , 1992, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[7] M. Vjecha,et al. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. , 1993, The Journal of infectious diseases.

[8] R. Sorensen,et al. Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago, Chile. , 1992, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[9] J. Sterne,et al. Incidence rates of leprosy in Karonga District, northern Malawi: patterns by age, sex, BCG status and classification. , 1994, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[10] L. Bliss,et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi , 1992, The Lancet.

[11] I. Sutherland,et al. BCG vaccination of children against leprosy in Uganda: final results , 1981, Journal of Hygiene.

[12] J. Sterne,et al. Geographic determinants of leprosy in Karonga District, Northern Malawi. , 1995, International journal of epidemiology.

[13] I. Sutherland,et al. A re-examination of the variations in the efficacy of BCG vaccination against tuberculosis in clinical trials. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14] P. Fine,et al. Leprosy in Malawi. 2. Background, design and prospects of the Karonga Prevention Trial, a leprosy vaccine trial in northern Malawi. , 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[15] J. Convit,et al. Immunoprophylactic trial with combined Mycobacterium Leprae/BCG vaccine against leprosy: preliminary results , 1992, The Lancet.

[16] D. Hom,et al. Accelerated course of human immunodeficiency virus infection after tuberculosis. , 1995, American journal of respiratory and critical care medicine.

[17] A. Merianos,et al. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79. , 1989, Bulletin of the World Health Organization.

[18] J. Sterne,et al. Testing for antibody to human immunodeficiency virus type 1 in a population in which mycobacterial diseases are endemic. , 1995, The Journal of infectious diseases.

[19] J. Pönnighaus,et al. Does the introduction of WHO-MDT influence trends in the incidence of leprosy?--the Malaŵian experience. , 1993, Leprosy review.

[20] P. Fine,et al. Certainty levels in the diagnosis of leprosy. , 1987, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[21] J. Pönnighaus,et al. Hypersensitivity to dextran in BCG vaccine , 1991, The Lancet.

[22] V. Diwan,et al. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. , 1993, International journal of epidemiology.

[23] P. E. M. Fine,et al. Variation in protection by BCG: implications of and for heterologous immunity , 1995, The Lancet.

[24] L. M. Bechelli,et al. BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma. , 1985, Bulletin of the World Health Organization.

[25] P. Fine,et al. The BCG Experience: Implications for Future Vaccines against Tuberculosis , 1994 .